International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

Authors

Spyridon Miyakis, University of AthensFollow
M Lockshin, Cornell Medical Center, New York
T Atsumi, Hokkaido University
D Branch, University of Utah
R Brey, University of Texas
R Cevera, Lipid Clinic, Hospital Clinic, Barcelona, Spain
R Derksen, University Medical Center, Utrecht
P De Groot, University Medical Center, Utrecht
T Koike, Hokkaido University
P Meroni, University of Milan
G Reber, University Hospital, Geneva
Y Shoenfeld, Tel-Hashomer And Tel Aviv University
A Tincani, University of Brescia
P Vlachoyiannopoulos, University of Athens
S Krilis, St. George Hospital, Sydney

RIS ID

74489

Publication Details

Miyakis, S., Lockshin, M., Atsumi, T., Branch, D., Brey, R., Cevera, R., Derksen, R., De Groot, P., Koike, T., Meroni, P., Reber, G., Shoenfeld, Y., Tincani, A., Vlachoyiannopoulos, P. & Krilis, S. (2006). International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Journal of Thrombosis and Haemostasis, 4 (2), 295-306.

Abstract

New clinical, laboratory and experimental insights, since the 1999 publication of the Sapporo preliminary classification criteria for antiphospholipid syndrome (APS), had been addressed at a workshop in Sydney, Australia, before the Eleventh International Congress on antiphospholipid antibodies. In this document, we appraise the existing evidence on clinical and laboratory features of APS addressed during the forum. Based on this, we propose amendments to the Sapporo criteria. We also provide definitions on features of APS that were not included in the updated criteria.